About company
Admetsys has developed a first-of-its-kind artificial pancreas for hospital and surgical care, leveraging adaptive learning algorithms and counterbalancing treatment of insulin and glucose. The system has undergone 3 successful FDA-approved clinical trials with 97% control between 80–125 mg/dl and zero incidents of low blood sugar.
- US
- Unknown
- Unknown
- admetsys.com
- Not verified company
